374 related articles for article (PubMed ID: 21625572)
1. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
Hamasaki T; Okamoto M; Baba M
Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
[TBL] [Abstract][Full Text] [Related]
3. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435
[TBL] [Abstract][Full Text] [Related]
4. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
[TBL] [Abstract][Full Text] [Related]
5. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
[TBL] [Abstract][Full Text] [Related]
6. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
[TBL] [Abstract][Full Text] [Related]
7. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
[TBL] [Abstract][Full Text] [Related]
9. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
10. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication.
Hamy F; Felder ER; Heizmann G; Lazdins J; Aboul-ela F; Varani G; Karn J; Klimkait T
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3548-53. PubMed ID: 9108013
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
12. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
[TBL] [Abstract][Full Text] [Related]
15. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
[TBL] [Abstract][Full Text] [Related]
16. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
Du Z; Lind KE; James TL
Chem Biol; 2002 Jun; 9(6):707-12. PubMed ID: 12079782
[TBL] [Abstract][Full Text] [Related]
17. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
18. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA
J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367
[TBL] [Abstract][Full Text] [Related]
20. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
Shortridge MD; Wille PT; Jones AN; Davidson A; Bogdanovic J; Arts E; Karn J; Robinson JA; Varani G
Nucleic Acids Res; 2019 Feb; 47(3):1523-1531. PubMed ID: 30481318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
